BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$156M |
| 2 |
SPDR Gold Trust
GLD
|
+$142M |
| 3 |
Bank of America
BAC
|
+$107M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$92.9M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.53B |
| 2 |
Equinix
EQIX
|
+$2B |
| 3 |
Gilead Sciences
GILD
|
+$1.63B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.48B |
| 5 |
United Therapeutics
UTHR
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.55% |
| 2 | Technology | 24.39% |
| 3 | Consumer Discretionary | 8.23% |
| 4 | Materials | 5.85% |
| 5 | Real Estate | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALY
2801
Callaway Golf Company
CALY
$2.95B
| $7.78K | ﹤0.01% |
923
-18,351
| -95% | -$146K |
|
|
ARI
2802
Apollo Commercial Real Estate
ARI
$885M
| $7.77K | ﹤0.01% |
478
-9,549
| -95% | -$155K |
|
2803
PUT
Seagate
STX
$209B
| $7.77K | ﹤0.01% |
+2,082
| New | +$103K |
|
|
ASRT
2804
DELISTED
Assertio
ASRT
| $7.75K | ﹤0.01% |
12
-246
| -95% | -$120K |
|
2805
Park Aerospace
PKE
$811M
| $7.75K | ﹤0.01% |
+270
| New | +$7.65K |
|
|
NXTM
2806
DELISTED
NxStage Medical Inc.
NXTM
| $7.75K | ﹤0.01% |
775
-15,542
| -95% | -$176K |
|
2807
Ezcorp Inc
EZPW
$1.78B
| $7.74K | ﹤0.01% |
662
-13,199
| -95% | -$175K |
|
|
ZOLT
2808
DELISTED
ZOLTEK COMPANIES INC
ZOLT
| $7.74K | ﹤0.01% |
+462
| New | +$7.72K |
|
|
IDIX
2809
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| $7.74K | ﹤0.01% |
1,294
-24,943
| -95% | -$115K |
|
|
ATSG
2810
DELISTED
Air Transport Services Group
ATSG
| $7.73K | ﹤0.01% |
956
-13,580
| -93% | -$101K |
|
|
TESO
2811
DELISTED
Tesco Corp
TESO
| $7.71K | ﹤0.01% |
+390
| New | +$7.03K |
|
2812
Myers Industries
MYE
$1.23B
| $7.71K | ﹤0.01% |
+365
| New | +$7.1K |
|
2813
Columbus McKinnon
CMCO
$550M
| $7.71K | ﹤0.01% |
+284
| New | +$7.42K |
|
2814
STAAR Surgical
STAA
$1.26B
| $7.71K | ﹤0.01% |
+476
| New | +$6.37K |
|
|
HSII
2815
DELISTED
Heidrick & Struggles
HSII
| $7.69K | ﹤0.01% |
+382
| New | +$7.06K |
|
|
MVC
2816
DELISTED
MVC Capital, Inc.
MVC
| $7.68K | ﹤0.01% |
+569
| New | +$7.87K |
|
|
EPIQ
2817
DELISTED
EPIQ SYSTEMS INC
EPIQ
| $7.67K | ﹤0.01% |
+473
| New | +$7.18K |
|
2818
PUT
Ameriprise Financial
AMP
$49.9B
| $7.67K | ﹤0.01% |
515
-1,009
| -66% | -$104K |
|
2819
Stride
LRN
$3.27B
| $7.66K | ﹤0.01% |
352
-7,049
| -95% | -$147K |
|
2820
Griffon
GFF
$4.8B
| $7.63K | ﹤0.01% |
578
-11,896
| -95% | -$152K |
|
2821
Insmed
INSM
$28.9B
| $7.63K | ﹤0.01% |
+449
| New | +$6.88K |
|
2822
Interparfums
IPAR
$3.78B
| $7.63K | ﹤0.01% |
+213
| New | +$7.32K |
|
|
BNNY
2823
DELISTED
ANNIES INC COMMON STOCK (DE)
BNNY
| $7.62K | ﹤0.01% |
+177
| New | +$8.25K |
|
2824
The Bancorp
TBBK
$2.83B
| $7.61K | ﹤0.01% |
+425
| New | +$7.44K |
|
|
ARRY
2825
DELISTED
Array Biopharma Inc
ARRY
| $7.59K | ﹤0.01% |
1,515
-30,308
| -95% | -$165K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2013 Portfolio in Review
As of Q4 2013, BNP Paribas Financial Markets held 4,298 positions worth $137B, down 0.25% from $137B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
BNP Paribas Financial Markets withdrew a net $60.2B in Q4 2013, closing 193 positions and reducing 1,811 holdings. Its most notable exit was Innoviva, an estimated $182M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, BNP Paribas Financial Markets opened a new position in Ambev worth $22.5M.
- BNP Paribas Financial Markets's largest Q4 2013 buy was Ambev: 3,066,560 shares worth $22.5M.
- BNP Paribas Financial Markets added most to Apple in Q4 2013, an estimated $156M increase.
- BNP Paribas Financial Markets's biggest Q4 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.53B.
- BNP Paribas Financial Markets fully exited Innoviva in Q4 2013, selling an estimated $182M.
- BNP Paribas Financial Markets's ten largest holdings make up 38% of its $137B portfolio in Q4 2013.
- BNP Paribas Financial Markets opened 1,712 new positions and closed 193 in Q4 2013.
- BNP Paribas Financial Markets's portfolio value fell 0.25% quarter-over-quarter to $137B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2013, filed 12 Feb 2014.